-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STEBVax in Staphylococcus aureus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STEBVax in Staphylococcus aureus Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STEBVax in Staphylococcus aureus Infections Drug Details: STEBVax is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STEBVax in Toxic Shock
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STEBVax in Toxic Shock report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STEBVax in Toxic Shock Drug Details: STEBVax is under development for...
-
Product Insights
NewMethicillin-Resistant Staphylococcus aureus (MRSA) Infections – Drugs In Development, 2024
Empower your strategies with our Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Methicillin-resistant Staphylococcus aureus (MRSA) infections that are acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-acquired MRSA (CA-MRSA) infections; others are hospital-aquired (HA-MRSA). Risk factors for MRSA infection are hemodialysis, weakened immune system, admission to hospitals, and wounds. Symptoms include skin...
-
Product Insights
NewEbolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain, and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids, and pain relievers. The Ebolavirus Infections (Ebola Hemorrhagic Fever) drugs in development market...
-
Product Insights
NewHepatitis C – Drugs In Development, 2024
Empower your strategies with our Hepatitis C – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis C is a contagious viral infection affecting the liver. It spreads on contact with infected blood. It may be a mild condition or may be chronic, leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea, and vomiting. The predisposing factors of hepatitis C include dialysis, organ transplant, and blood transfusion. The offspring of...
-
Product Insights
NewChikungunya Fever – Drugs In Development, 2024
Empower your strategies with our Chikungunya Fever – Drugs In Development, 2024 report and make more profitable business decisions. Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting, and rash and fever. Treatment includes use of non-steroidal...
-
Product Insights
NewMarburgvirus Infections (Marburg Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Marburgvirus Infections (Marburg Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Marburg hemorrhagic fever is a rare, acute infectious disease that affects both human and nonhuman primates. Symptoms include fever, headache, chills, weakness, diarrhea, stomach pain, and weight loss. The Marburgvirus Infections (Marburg Hemorrhagic Fever) drugs in development market research report provide comprehensive information on the therapeutics under development for Marburgvirus Infections (Marburg Hemorrhagic Fever), complete with analysis by stage...
-
Product Insights
NewEquine Encephalitis – Drugs In Development, 2024
Empower your strategies with our Equine Encephalitis – Drugs In Development, 2024 report and make more profitable business decisions. Eastern Equine Encephalitis (EEE) is a rare but serious viral disease that affects humans and horses, caused by the Eastern Equine Encephalitis virus (EEEV), belonging to the Togaviridae family. The virus is primarily transmitted through the bite of infected mosquitoes, belonging to the Culiseta melanura species. The symptoms of EEE in humans can range from mild flu-like symptoms to more severe cases...
-
Product Insights
NewOsteomyelitis – Drugs In Development, 2024
Empower your strategies with our Osteomyelitis – Drugs In Development, 2024 report and make more profitable business decisions. Osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby tissue. Symptoms include fever, pain in the area of the infection, swelling, warmth and redness over the area of the infection, and irritability. Risk factors bone fracture, sickle cell disease, chemotherapy, diabetes, and peripheral arterial disease. Treatment includes surgery and oral antibiotics....
-
Product Insights
Collagens Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Collagens Pipeline Market Report Overview Collagen dressings are typically made up of a combination of animal collagen and any other formulation for structural integrity, and sodium or calcium ions. These are available in many forms such as sheets, gels, pads, particles, and pastes. The Collagens pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...